isoproterenol has been researched along with xanthohumol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaiz-Cot, JJ; Cleemann, L; Morad, M | 1 |
| Li, WQ; Liu, XY; Sun, TL; Tong, XL; Zhou, WH | 1 |
2 other study(ies) available for isoproterenol and xanthohumol
| Article | Year |
|---|---|
Xanthohumol Modulates Calcium Signaling in Rat Ventricular Myocytes: Possible Antiarrhythmic Properties.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Signaling; Dose-Response Relationship, Drug; Electric Stimulation; Flavonoids; Heart Ventricles; Isoproterenol; Male; Myocytes, Cardiac; Propiophenones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Temperature | 2017 |
Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway.
Topics: Animals; Disease Models, Animal; Fibrosis; Flavonoids; Hypertrophy, Left Ventricular; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Propiophenones; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2021 |